R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K149.5 KBRevance Therapeutics, Inc.Aug 30, 7:20 PM ET·0001479290-23-000101
- SC 13G/A18.3 KBRevance Therapeutics, Inc.Feb 13, 2:49 PM ET·0001422849-23-000128
- SC 13G/A13.0 KBRevance Therapeutics, Inc.Feb 9, 11:30 AM ET·0001104659-23-016848
- SC 13G/A13.4 KBRevance Therapeutics, Inc.Feb 3, 4:27 PM ET·0001306550-23-007655
- 8-K177.8 KBRevance Therapeutics, Inc.Feb 3, 4:05 PM ET·0001479290-23-000017
- SC 13G/A89.9 KBRevance Therapeutics, Inc.Jan 27, 12:22 PM ET·0000019617-23-000167
- 8-K168.8 KBRevance Therapeutics, Inc.Apr 21, 4:11 PM ET·0001479290-22-000052
- 8-K179.1 KBRevance Therapeutics, Inc.Apr 12, 4:05 PM ET·0001479290-21-000097
- 45.8 KBRevance Therapeutics, Inc.Jan 3, 5:52 PM ET·0001209191-17-000398
- 44.8 KBRevance Therapeutics, Inc.Jan 4, 9:11 PM ET·0001209191-16-088106
Insiders
6Tickers
No tickers on record
Addresses
business
1222 DEMONBREUN STREET SUITE 2000
NASHVILLE, TN, 37203
mailing
1222 DEMONBREUN STREET SUITE 2000
NASHVILLE, TN, 37203